Naftifine Hydrochloride Patent Expiration
Naftifine Hydrochloride is Used for treating fungal infections. It was first introduced by Legacy Pharma Inc
Naftifine Hydrochloride Patents
Given below is the list of patents protecting Naftifine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Naftin | US10166205 | Topical compositions and methods for making and using same | Jan 31, 2033 | Legacy Pharma |
| Naftin | US10166206 | Topical compositions and methods for making and using same | Jan 31, 2033 | Legacy Pharma |
| Naftin | US10695303 | Topical compositions and methods for making and using same | Jan 31, 2033 | Legacy Pharma |
| Naftin | US10729667 | Topical compositions and methods for making and using same | Jan 31, 2033 | Legacy Pharma |
| Naftin | US8778365 | Topical compositions and methods for making and using same | Jan 31, 2033 | Legacy Pharma |
| Naftin | US9161914 | Topical compositions and methods for making and using same | Jan 31, 2033 | Legacy Pharma |
Naftifine Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Naftifine Hydrochloride Generic API Manufacturers
Several generic applications have been filed for Naftifine Hydrochloride. The first generic version for Naftifine Hydrochloride was by Taro Pharmaceuticals Inc and was approved on Jan 6, 2016. And the latest generic version is by Xiromed Pharma Espana Sl and was approved on Sep 22, 2020.
Given below is the list of companies who have filed for Naftifine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.
1. AMNEAL
Amneal Pharmaceuticals Llc has filed for 2 different strengths of generic version for Naftifine Hydrochloride. Given below are the details of the strengths of this generic introduced by Amneal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2% | cream | Prescription | TOPICAL | AB | Apr 10, 2017 |
| 1% | gel | Prescription | TOPICAL | AB | Mar 20, 2019 |
Manufacturing Plant Locations New
Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
| India |
| |||||||||||||||||
2. TARO
Taro Pharmaceuticals Inc has filed for 2 different strengths of generic version for Naftifine Hydrochloride. Given below are the details of the strengths of this generic introduced by Taro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2% | gel | Prescription | TOPICAL | AB | Apr 10, 2019 |
| 1%
(reference standard) | cream | Prescription | TOPICAL | N/A | Sep 8, 2016 |
Manufacturing Plant Locations New
Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| Israel |
| |||||
| Canada |
| |||||
3. XIROMED
Xiromed Pharma Espana Sl has filed for 1 generic for Naftifine Hydrochloride. Given below are the details of the strengths of this generic introduced by Xiromed.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2% | cream | Prescription | TOPICAL | AB | Sep 22, 2020 |
Manufacturing Plant Locations New
Xiromed's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Xiromed as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||